Astex Pharmaceuticals
| Company type | Subsidiary |
|---|---|
| Industry | Pharmaceuticals |
| Founded | 1999 |
| Headquarters | European Corporate and Research headquarters in Cambridge, UK (Astex Therapeutics Limited) |
Key people | Harren Jhoti (President and CEO) David Rees (Chief Scientific Officer) |
| Products | Therapeutics for oncology and CNS disorders |
| Parent | Otsuka Pharmaceutical |
| Website | astx |
Astex Pharmaceuticals is a biotechnology company focused on the discovery and development of drugs in oncology and diseases of the central nervous system. Astex was founded in 1999 by Sir Tom Blundell, Chris Abell and Harren Jhoti, and is located in Cambridge, England.
Astex is part of the Otsuka group of companies and is a wholly owned subsidiary of Otsuka Pharmaceutical Co. Ltd, headquartered in Tokyo, Japan.